If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Omvoh ™ (mirikizumab-mrkz) injection
300 mg/15 mL, 100 mg/mL
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Can I travel with Omvoh™ (mirikizumab-mrkz)?
When traveling with Omvoh (mirikizumab) store the pens at 36°F to 46°F. Do not shake or freeze the pens. The pens can be stored at room temperature (up to 86°F) for up to 14 days. Only travel with unused pens and do not store the pens in checked luggage.
Traveling With Omvoh
Storing Omvoh for Travel
Protect Omvoh pens from light by storing them in the original carton (or any container that will protect them from all types of light, eg, a brown paper bag or covered with a dish towel) until the patient is ready to use them.1,2
If needed, Omvoh pens can be intentionally stored at room temperature (up to 86°F) for up to 14 days. Patients may choose to use this 14-day room temperature storage allowance while traveling. Once a patient decides to start using the 14-day allowance, Omvoh must not be returned to the refrigerator/refrigeration.1,2
Do not use Omvoh pens if they were exposed to temperatures above 86°F or if Omvoh pens were stored at room temperature for longer than 14 days.1
Where to Pack Omvoh
It is recommended that patients keep Omvoh pens with them while traveling, such as in their carry-on luggage. Temperatures in luggage-hold areas, where checked-in luggage is usually stored, or car trunks may be too cold or too hot for Omvoh.2
Patients may decide to purchase a cooler to keep their Omvoh pens at 36°F to 46°F when traveling.2
Eli Lilly and Company (Lilly) does not test, market, or sell these products for Omvoh, so we are not able to recommend a specific type of travel storage cooler.2
If one of these travel storage coolers is used, it is important to remember that the Omvoh pen should not touch ice or frozen gel packs as this may lead the pen to freeze.2
Bringing Omvoh Through TSA Security
A special letter from the patient's health care prescriber should not be needed.2
Most airlines allow medical devices with needles on board the plane as long as the needles are not exposed (eg, unused, capped Omvoh pens).2
The Omvoh prescription label should be kept with the medicine. The Transportation Security Administration (TSA) agent may ask for this label to verify that the Omvoh pens and any associated supplies belong to the patient.2
When the patient reaches the security checkpoint, tell the TSA agent that the patient is carrying an injectable prescription medication. Separate the Omvoh pens and any other medical supplies to be used with your Omvoh pens from your other belongings and proceed as directed by the TSA agent.2
The short period of time Omvoh pens are exposed to light during an inspection will not harm the medicine. Make sure to return Omvoh pens to their light-protective container once the security screening is completed.2
X-rays are not known to affect the medicine in the Omvoh pens.2
Eli Lilly and Company has not specifically completed x-ray studies for Omvoh. However, previously completed studies for other similar injectable Lilly medicines have confirmed that the x-rays from airport security scanners do not harm these types of medicines.2
Changes in altitude when traveling do not impact Omvoh.2
Airlines, transportation companies, and other countries may have additional rules and restrictions. Patients should check with their airline or transportation company for more information. If traveling internationally, patients should also check with the authorities in the countries they are visiting.
Additionally, security regulations continuously change, it is recommended that patients contact TSA at 1-866-289-9673 for the latest guidance in traveling with medicine and needles or visit the TSA website at Transportation Security Administration | Transportation Security Administration (tsa.gov).
Enclosed Prescribing Information
1Omvoh [package insert]. Indianapolis, IN: Eli Lilly and Company; 2023.
2Data on file, Eli Lilly and Company and/or one of its subsidiaries.
Date of Last Review: March 14, 2023